Bacil Pharma Limited (BSE: 524516)
Health Care · Pharmaceuticals · IN
Rs24.77
-9.20% today · -42.4% 1Y
Bacil Pharma Limited (BSE: 524516) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.67M.
Over the last twelve months the share price has lost 42.4%, trading between 10.65 and 61.80.
Tweenvest scores Bacil Pharma Limited across four factors: quality 61/100, value 59/100. Its strongest factor is quality.
524516 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.67M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.15
- 52-week high
- Rs61.80
- 52-week low
- Rs10.65
- Avg volume (3M)
- —
- Shares outstanding
- 14.35M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MYND Life Sciences Inc.CNSX: MYND | $3.77M | CA$— | — |
| Green Zebras Spolka AkcyjnaWSE: GRZ | $3.77M | zł9.30 | 0.00% |
| Murae Organisor LimitedBSE: 542724 | $3.76M | Rs— | — |
| Jupiter Neurosciences, Inc.NasdaqCM: JUNS | $3.76M | $3.00 | +5.26% |
| WEED, Inc.OTCPK: BUDZ | $3.66M | $0.02 | -3.52% |
| 1933 Industries Inc.CNSX: TGIF | $3.65M | CA$0.01 | +100.00% |
| SenesTech, Inc.NasdaqCM: SNES | $3.63M | $0.64 | -4.45% |
| Addex Therapeutics LtdSWX: ADXN | $3.56M | CHF0.02 | +4.50% |
Figures last refreshed Oct 11, 2026.